Advertisement

Author: Alan Condon

The FDA has cleared Genentech's Evrysdi drug for spinal muscular atrophy in adults and children 2 months of age and older, according to an Aug. 10 announcement.

Advertisement

During NuVasive's second-quarter earnings call, CEO Chris Barry said the timeline for its Pulse robotic system for spine surgery has been further delayed, according to Seeking Alpha.

Advertisement